drugset
drugset / Trial / NCT01926548

to Evaluate the Pharmacokinetics(Cmax, Auc) of CJ Imatinib Mesylate Tablet 200mg x 1 Compared With Gleevec Film-coated Tablet 100mg x 2 in Healthy Male Volunteers

NCT01926548 ↗

Phase 1 Completed 28 enrolled HK inno.N Corporation
RandomizedCrossoverOpen-labelBasic science

Summary

This study is designed to evaluate the pharmacokinetics of CJ Imatinib mesylate tablet 1 x 200mg compared with Gleevec film-coated tablet 2 x 100mg in healthy male volunteers.

Timeline

Start
2012-02
Primary completion
2012-03
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gleevec film-coated tablet 2 x 100mg Unknown 200 mg Oral
Subject Imatinib Small molecule 200 mg Oral

Indications

No indication recorded.